###begin article-title 0
###xml 30 35 <span type="species:ncbi:9606">human</span>
Transcriptional regulation of human eosinophil RNases by an evolutionary- conserved sequence motif in primate genome
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnase</italic>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human eosinophil-derived neurotoxin (edn) and eosinophil cationic protein (ecp) are members of a subfamily of primate ribonuclease (rnase) genes. Although they are generated by gene duplication event, distinct edn and ecp expression profile in various tissues have been reported.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnases</italic>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 677 686 677 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 690 698 690 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 881 885 881 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1006 1010 1006 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 357 362 <span type="species:ncbi:9606">human</span>
In this study, we obtained the upstream promoter sequences of several representative primate eosinophil rnases. Bioinformatic analysis revealed the presence of a shared 34-nucleotide (nt) sequence stretch located at -81 to -48 in all edn promoters and macaque ecp promoter. Such a unique sequence motif constituted a region essential for transactivation of human edn in hepatocellular carcinoma cells. Gel electrophoretic mobility shift assay, transient transfection and scanning mutagenesis experiments allowed us to identify binding sites for two transcription factors, Myc-associated zinc finger protein (MAZ) and SV-40 protein-1 (Sp1), within the 34-nt segment. Subsequent in vitro and in vivo binding assays demonstrated a direct molecular interaction between this 34-nt region and MAZ and Sp1. Interestingly, overexpression of MAZ and Sp1 respectively repressed and enhanced edn promoter activity. The regulatory transactivation motif was mapped to the evolutionarily conserved -74/-65 region of the edn promoter, which was guanidine-rich and critical for recognition by both transcription factors.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 233 239 233 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnase </italic>
###xml 125 130 <span type="species:ncbi:9606">human</span>
Our results provide the first direct evidence that MAZ and Sp1 play important roles on the transcriptional activation of the human edn promoter through specific binding to a 34-nt segment present in representative primate eosinophil rnase promoters.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 636 637 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 785 786 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 787 788 783 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 841 844 837 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 858 861 854 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 948 950 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 951 953 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 964 968 960 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1046 1050 1042 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1054 1058 1050 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1262 1264 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1293 1297 1289 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1301 1305 1297 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1437 1439 1433 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1590 1592 1586 1588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1593 1595 1589 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1720 1722 1716 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1723 1725 1719 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 241 246 <span type="species:ncbi:9606">human</span>
###xml 704 709 <span type="species:ncbi:4932">yeast</span>
###xml 772 777 <span type="species:ncbi:9606">human</span>
Human edn and ecp respectively encode eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP), two of the four major proteins found in granules of human eosinophilic leukocytes. Their gene products belong to members of the human RNaseA superfamily, which comprises RNase1-13 [1-6]. The eosinophil RNases EDN and ECP are secreted to body fluid and have neurotoxic, helminthotoxic, and ribonucleolytic activities. Previously, we demonstrated that ECP enters neuroendocrine cells through protein-protein interactions with a granular protease, which in turn allows the cytotoxic ECP to inhibit growth of the target cells [7]. In addition, the signal peptide of ECP is toxic to bacteria and yeast and induces expression of transforming growth factor alpha in human cells [8,9]. Although both genes are expressed in eosinophils, edn, rather than ecp, can be extensively expressed in various tissues including liver, spleen, and kidney [10-12], whereas ecp is restrictively expressed in blood granulocytes. In terms of gene structure, edn and ecp are similar as they both contain an intron between a noncoding exon 1 and a coding exon 2. Each of these genes is translated from exon 2, and the sequence identity of the DNA in the coding region is 85% [13]. It has been proposed that edn and ecp were evolved through a duplication event about 31 million years ago in the evolutionary lineage of New World and Old World monkeys [14]. Gene duplication and subsequent functional divergence of duplicated genes is one of the important mechanisms for evolution of novel gene functions [15-18]. However, the regulatory motifs in promoter regions of duplicated genes are generally conserved during duplication events [19-21].
###end p 9
###begin p 10
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 347 350 347 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 494 501 494 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnases </italic>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 548 552 548 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 333 338 <span type="species:ncbi:9606">human</span>
Previously, three important transcription factor binding sites, C/EBP, NFAT-1 and PU.1 were discovered in the promoter regions of both edn and ecp, and the non-translating exon 1 as well as intron 1 could enhance the promoter activities [22-26]. Although as high as 92% sequence identity was observed in the upstream 1-kb regions of human edn and ecp, much higher edn promoter activity was observed. Therefore, whether any sequence stretch located in the upstream regions of primate eosinophil rnases may govern regulatory transcription of ecp and edn was investigated employing cross-species sequence comparison, transcription element prediction and functional validation.
###end p 10
###begin title 11
Result
###end title 11
###begin title 12
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
Primate edn and ecp promoters share high sequence similarity
###end title 12
###begin p 13
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnase </italic>
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 305 344 305 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. pygmaeus, G. gorilla, P. troglodytes</italic>
###xml 369 384 369 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. fascicularis</italic>
###xml 413 424 413 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. sciureus</italic>
###xml 588 592 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 768 783 768 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. troglodytes </italic>
###xml 796 800 796 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 804 808 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 119 124 <span type="species:ncbi:9606">human</span>
###xml 299 303 <span type="species:ncbi:4456">apes</span>
###xml 305 316 <span type="species:ncbi:9600">P. pygmaeus</span>
###xml 318 328 <span type="species:ncbi:9593">G. gorilla</span>
###xml 330 344 <span type="species:ncbi:9598">P. troglodytes</span>
###xml 369 384 <span type="species:ncbi:9541">M. fascicularis</span>
###xml 413 424 <span type="species:ncbi:9521">S. sciureus</span>
###xml 768 782 <span type="species:ncbi:9598">P. troglodytes</span>
###xml 784 794 <span type="species:ncbi:9598">chimpanzee</span>
We amplified and sequenced primate eosinophil rnase promoter fragments, -921 to -1 [22] and -937 to -1 relative to the human edn and ecp transcription start site, respectively [27], from individual of six nonhuman primate species. These primate species represent independent genera from three great apes (P. pygmaeus, G. gorilla, P. troglodytes), one Old World monkey (M. fascicularis), and one New World monkey (S. sciureus). The sequence data have been submitted to GenBank (GenBank accession numbers -). Multiple sequence alignment by ClustalW showed that the identities among primate edn and ecp promoter sets were greater than 95% and 91%, respectively. In consistence with what Zhang and Rosenberg have characterized, the sequences of the 5' promoter regions of P. troglodytes (chimpanzee) edn and ecp determined in this study were identical to those reported in AF294016-AF294018 and AF294027-294028, respectively [18].
###end p 13
###begin title 14
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
Comparative analysis reveals deletion of a 34-nt segment in the ecp promoter
###end title 14
###begin p 15
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 138 145 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnases </italic>
###xml 245 252 245 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnases </italic>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 618 622 618 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edns</italic>
###xml 632 636 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 678 685 678 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnases </italic>
###xml 869 875 869 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnase </italic>
Conventional multiple sequence alignment of primate edn and ecp promoters revealed greater than 90% identity in the duplicated eosinophil rnases in each species, indicating that the promoter sequence patterns of all sequenced primate eosinophil rnases were quite similar. Interestingly, MISA analysis of 11 promoters showed a remarkably high degree of similarity as illustrated by the color-coded bars, and a 34-nt segment with significantly high variation was located at -81 to -48 as indicated by dotted grey grids (Fig. 1A). This characteristic sequence motif was present in promoters of all representative primate edns, but for ecp only in macaque. Since primate eosinophil rnases have been recognized to be emerged from a gene duplication event after divergence of Old World monkeys and New World monkeys, this finding suggests the possibility that the eosinophil rnase promoters might have further evolved after the duplication event.
###end p 15
###begin p 16
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A 34-nt region is present in primate <italic>edn </italic>and macaque <italic>ecp </italic>promoters</bold>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 484 488 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
A 34-nt region is present in primate edn and macaque ecp promoters. (A) MISA of primate edn and ecp promoters. The grey dotted grids represent regions lacking common nucleotide sequences, and their heights represent the relative level of residue variation. The color-coded bars represent homologous regions. (B) Multiple sequence alignment of primate edn and ecp promoters by ClustalW with the conserved motifs in the 34-nt region indicated. (C) Phylogenic relationship among primate edn and ecp promoters using MEGA 3.1.
###end p 16
###begin p 17
###xml 97 100 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-74</sup>
###xml 110 113 110 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-65</sup>
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-62</sup>
###xml 138 141 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-48</sup>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnase </italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 586 590 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 701 705 701 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 246 251 <span type="species:ncbi:9606">human</span>
###xml 274 279 <span type="species:ncbi:9606">human</span>
Subsequently, we were able to distinguish within the 34-nt region two conserved sequence motifs "-74ACCCTCCCTC-65" and "-62GGCTCTGCTGGCCCA-48" (Fig. 1B). The Furthermore, primate eosinophil rnase promoter sequences corresponding to -921 to -1 of human edn and -887 to -1 of human ecp were analyzed by MEGA 3.1, and the phylogenetic relationship between ecp and edn promoter sequences among different species is was illustrated in Figure 1C. The results showed that the ecp and edn promoters branched when the 34-nt segment disappeared in some species, in agreement with the notion that ecp and edn were the most rapidly evolving coding sequences of primate genes [4]. The phylogenetic tree of ecp and edn promoter sequences suggested another evolutional event by which deletion of the 34-nt sequence stretch might have occurred in the lineage Old Word monkey and hominoid.
###end p 17
###begin title 18
Presence of the 34-nt segment enhances transcriptional activities
###end title 18
###begin p 19
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 462 466 462 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 470 474 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 529 533 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 673 677 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 681 684 681 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 836 840 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 844 848 844 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 976 980 976 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 981 984 981 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">epx</italic>
###xml 999 1000 999 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1069 1073 1069 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1077 1081 1077 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1160 1162 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1221 1225 1221 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1264 1267 1264 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 1290 1294 1286 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1300 1303 1296 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 1312 1316 1308 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1353 1356 1349 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 1466 1470 1462 1466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1476 1479 1472 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 1565 1569 1561 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1573 1577 1569 1573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1625 1629 1621 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1758 1761 1754 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 1836 1840 1832 1836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1896 1899 1892 1895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 1933 1937 1929 1933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 2074 2078 2070 2074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 2141 2145 2137 2141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 2149 2153 2145 2149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 2277 2281 2273 2277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 2285 2289 2281 2285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 2300 2302 2296 2298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 2325 2326 2321 2322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 2425 2428 2421 2424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 2575 2579 2571 2575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 1063 1068 <span type="species:ncbi:9606">human</span>
###xml 1215 1220 <span type="species:ncbi:9606">human</span>
###xml 1284 1289 <span type="species:ncbi:9606">human</span>
###xml 1306 1311 <span type="species:ncbi:9606">human</span>
###xml 1460 1465 <span type="species:ncbi:9606">human</span>
###xml 2271 2276 <span type="species:ncbi:9606">human</span>
Expression of human edn is dependent on the interaction between an intronic enhancer element(s) and the 5' promoter region [27]. The transcription activities of human edn and ecp promoters in hematopoietic cell lines were previously reported [24]. In addition, edn was demonstrated not only expressed in thymus but also in liver tissue [28], and its mRNA expression has been identified in hematopoietic cell line and liver tissue [11]. As shown in Fig. 2A, both edn and ecp mRNAs were expressed in HL-60 clone 15 cells, but only edn mRNA was detected in HepG2 cells. Therefore, HepG2 cell line was used for further investigation of differential transcription regulation of edn and ecp. In order to understand the sequences involved in the interaction, we constructed individually the +1 to +297 region containing exon 1 and intron 1 of ecp and edn promoters, along with the preceding promoter region into the pGL3-Basic plasmid. Here a liver cell line HepG2, known to express edn (epx) effectively [3,11] was used to investigate the transcriptional activities of human edn and ecp promoters in the presence and absence of the 34-nt segment. As shown in Figure 2B, HepG2 cells transfected with constructs containing human edn with the -81/-48 segment deleted (pGL3-ednDelta(-81/-48)), human ecp (pGL3-ecp), human ecp with the 34-nt region inserted (pGL3-ecp+(-81/-48)) exhibited only 40%, 20% and 40% transcriptional activity, respectively, relative to that of human edn (pGL3-edn), indicating that presence of the 34-nt segment enhanced transcriptional activity of edn and ecp promoters. Removal of the 34-nt region from the edn promoter led to a 60% reduction in transcriptional activity, suggesting that the 34-nt segment was critical for transcription of edn. Interestingly, when the 34-nt segment was artificially inserted into the ecp promoter in the region corresponding to its position in edn, the transcriptional activity of ecp increased two fold. Our results demonstrated that the presence of the 34-nt segment correlated with enhanced transcriptional activity of ecp in HepG2 cells. Similarly, the 34-nt segment also enhanced the edn and ecp promoter activities in HL-60 clone 15 cells; cell of hematopoietic origin known to have transcriptional activities of human edn and ecp promoters [24]. (Supplementary Fig. 1). Thus, we postulated that a novel regulatory motif(s) residing in the promoter region of primate edn, especially those in the 34-nt segment, played an important role in regulating transactivation in liver and hematopoietic cells. Furthermore, the edn promoter activity dramatically reduced in response to the ablation of intron-based enhancer element no matter in the presence or absence of the 34-nt segment (unpublished data), indicating that the regulatory effect of the intronic enhancer was not correlated to the unique 34-nt segment.
###end p 19
###begin p 20
###xml 0 116 0 116 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The role of the conserved regions -74/-65 and -62/-48 in the 34-nt region in transcriptional activity in HepG2 cells</bold>
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 304 308 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 552 556 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 699 702 699 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 709 712 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 734 738 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 758 762 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1062 1064 1058 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The role of the conserved regions -74/-65 and -62/-48 in the 34-nt region in transcriptional activity in HepG2 cells. (A) Expression of edn and ecp mRNA in HepG2 and HL-60 clone 15 cells. Total RNA of HepG2 and HL-60 clone 15 were isolated and reverse-transcripted into cDNA. Specific primers for ecp or edn were used to amplify the cDNA. The PCR products were electrophoresed on a 2.0% agarose gel and stained with ethidium bromide. (B) HepG2 cells were transfected with the luciferase reporter plasmid pGL3 basic or the same vector containing edn or ecp upstream sequences with or without the 34-nt segment. (C) HepG2 cells were transfected with the luciferase reporter plasmid pGL3 basic or pGL3-edn, pGL3-ednDelta (-81/-48), pGL3-edn mut (-74/-65), pGL3-edn mut (-62/-48), respectively. The promoter activities were measured using the luciferase assay system. The average values of promoter activities were calculated as described in Methods and obtained from five independent experiments. The difference between the two groups is statistically significant (P < 0.05), as determined by the Wilcoxon Rank Sum test.
###end p 20
###begin p 21
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 80 83 80 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 151 154 151 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-74</sup>
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-65</sup>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-62</sup>
###xml 192 195 192 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-48</sup>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 240 241 240 241 <underline xmlns:xlink="http://www.w3.org/1999/xlink">T</underline>
###xml 254 255 254 255 <underline xmlns:xlink="http://www.w3.org/1999/xlink">E</underline>
###xml 262 263 262 263 <underline xmlns:xlink="http://www.w3.org/1999/xlink">S</underline>
###xml 269 270 269 270 <underline xmlns:xlink="http://www.w3.org/1999/xlink">S</underline>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 791 795 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 645 650 <span type="species:ncbi:9606">human</span>
Multiple sequence alignment of the 34-nt segment in all primate edn and macaque ecp, revealed the existence of two well conserved sequence stretches, "-74ACCCTCCCTC-65" and "-62GGCTCTGCTGGCCCA-48". The combination of ConSite [29] and TESS (Transcription Element Search System) [30] suggested several putative transcription factor binding sites, including Sp1, MAZ, activator protein-2 (AP2) and liver factor A1 (LF-A1) located at (-73/-65), (-73/-67), (-68/-60) and (-69/-55), respectively. As shown in Figure 2C, the transcription activities of reporters containing mutant -74 to -65 region and mutant region -62 to -48 were similar to that of human edn with the 34-nt segment deleted, indicating that each of the two conserved regions, -74/-65 and -62/-48, contribute to the regulation of edn transcription.
###end p 21
###begin title 22
Transcription elements for MAZ and Sp1 binding are present in the 34-nt segment
###end title 22
###begin p 23
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 234 242 234 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 310 315 <span type="species:ncbi:9606">human</span>
To elucidate whether the 34-nt region might play an important role in edn expression by serving as a recognition site for transcription factors, EMSA was performed to demonstrate binding between the 34-nt segment and nuclear proteins in vitro. Binding reactions between double-stranded probes derived from the human edn promoter sequence and HepG2 nuclear extracts produced one major shifted band and a less prominent shifted product (Fig. 3A, lane 1). Both shifted signals diminished with the addition of excess unlabeled 34-nt oligonucleotide (Fig. 3A, lane 2), suggesting that specific protein-DNA complexes are formed within this 34-nt region. Interestingly, mutant -74/-65 or mutant -62/-48 oligonucleotide did not compete with the major complex (Fig. 3A, lanes 3 and 4); however, the mutant -62/-48 oligonucleotide, but not mutant -74/-65, significantly competed with the minor band shift. Taken together, these results suggest that regions -62/-48 and -74/-65 serve as binding sites for transcription factors in HepG2 cells.
###end p 23
###begin p 24
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A novel MAZ binding motif in the 34-nt region</bold>
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 995 997 994 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
A novel MAZ binding motif in the 34-nt region. (A) The 32P-labeled 34-nt wild type (wt) probes were incubated with HepG2 nuclear extract, and the protein-DNA complexes were separated by 6% nondenaturing acrylamide gel electrophoresis. The DNA-protein complexes were competed by 200-fold molar excess of unlabeled wild type or mutant oligonucleotides. The major complex, minor complex, and free probe are indicated by an arrowhead, a star, and F, respectively. (B) The end-labeled wild type 34-nt probe was incubated with 20 mug cell nuclear extract proteins from HepG2 cells in the absence of competitor (lane 1) and presence of 200-fold molar excess of different unlabeled consensus oligonucleotides representing wild type 34-nt (lane 2), AP2 (lane 3), MAZ (lane 4), HNF-4 (lane 5), Sp1 (lane 6), LF-A1 (lane 7), c-myb (lane 8) and SRE (lane 9) promoter sequences. (C) The effect of 200-fold molar excess of mutant MAZ (mMAZ) and mutant Sp1 (mSp1) oligonucleotides on the mobility shift of the 32P-labeled wild type 34-nt sequence.
###end p 24
###begin p 25
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 1002 1004 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 1141 1143 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
ConSite and TESS predictions revealed that transcription factors AP2, MAZ, Sp1, and LF-A1 might bind to the 34-nt segment. In addition, since hepatocyte nuclear factor-4 (HNF-4) was reported to be identical to LF-A1 [31], an HNF-4 consensus sequence was also used to compete wild type binding along with the consensus oligonucleotides representing the other four transcription factor binding motifs. The results showed that the formation of the major band shift was completely abolished only by the MAZ consensus oligonucleotide (Fig. 3B, lane 4), but not consensus Sp1, LF-A1, HNF-4, and AP2 oligonucleotides, with serum responsive element (SRE) and c-myb oligonucleotides were used as negative controls. However, the formation of the minor shift was diminished by MAZ and Sp1 consensus oligonucleotides (Fig. 3C, lanes 2 and 4). Furthermore, when the mutant MAZ (mMAZ) oligonucleotide containing GA box mutation was used as an unlabeled competitor, it did not compete with the major band shift (Fig. 3C, lane 3). Likewise, mutant Sp1 competitor (mSp1) containing GC box mutation was unable to compete with the minor band shift ether (Fig. 3C, lane 5). These EMSA competition experiments clearly demonstrate that the transcription factors MAZ and Sp1 are involved in formation of protein-DNA complex in the 34-nt sequence stretch.
###end p 25
###begin title 26
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
MAZ binds to the 34-nt segment in vitro
###end title 26
###begin p 27
###xml 207 209 207 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 966 968 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1070 1072 1066 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1224 1228 1220 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
To confirm specific binding between MAZ and the wild type 34-nt segment, we conducted EMSA with nuclear extracts of HepG2 cells or recombinant MAZ in the presence of an antibody against MAZ (anti-MAZ). When 32P-labeled 34-nt oligonucleotide probe was reacted with HepG2 cell nuclear extract in the presence of anti-MAZ, no supershift representing the anti-MAZ-MAZ-DNA complex was observed, but there was a marked reduction in the major radiolabeled protein-DNA complex (Fig. 4A, lane 3), possibly due to the nature of anti-MAZ, which may recognize MAZ precisely at the DNA-binding domain. The third and fourth zinc fingers of MAZ are essential for its DNA binding activity [32]. We next used purified recombinant GST-MAZ and GST-MAZDeltaF34, a mutant MAZ lacking the third and fourth zinc fingers indispensable for its DNA binding activity in EMSA experiment. As expected, the presence of an increased amount of the former led to elevated DNA binding activity (Fig. 4B, lanes 1 to 4, upper panel), but that of the latter did not recognize the 34-nt segment at all (Fig. 4B, lanes 5 to 8, upper panel). Taken together, these results indicate that MAZ may specifically recognize and bind to the 34-nt segment derived from the edn promoter.
###end p 27
###begin p 28
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of the transcription factors that recognize the wild type 34-nt segment</bold>
###xml 227 232 <span type="species:ncbi:10090">mouse</span>
Identification of the transcription factors that recognize the wild type 34-nt segment. (A) In the presence of anti-MAZ, EMSA gel shift reactions were preincubated with of monoclonal anti-MAZ (lane 3) or control antibody (anti-mouse IgG; lane 2) for 30 min prior to the addition of the labeled wild type 34-nt probe. The position of the major protein/DNA complex and free probe is indicated by an arrowhead and F, respectively. (B) Purified recombinant GST-MAZ (lanes 1 to 4) and GST-MAZDeltaF34 (lanes 5 to 8) were expressed, purified, and used for EMSA with the wild type 34-nt probe.
###end p 28
###begin title 29
The -73/-67 and -62/-52 regions in the 34-nt segment are important for MAZ binding
###end title 29
###begin p 30
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1020 1024 1020 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1014 1019 <span type="species:ncbi:9606">human</span>
To map the exact MAZ-binding motif located the 34-nt segment, mutagenesis scanning was performed employing 21 probes covering serial tri- or di-nucleotide mutations as listed in supplementary Table 2. Unlabeled 200-fold molar excess wild type 34-nt oligonucleotide could abolish the specific shift of the MAZ complex (Fig. 5A, lane 2). Results in Fig. 5A indicated that no significant competition occurred when the m1, m2 and m3 competitors were used, suggesting that an essential MAZ binding site existed in the -74 to -66 region, most likely at the CCCTCCC motif that is equivalent to a known transcription element GA box [33]. However, m4, m5, m6, m7 and m8 oligonucleotides effectively competed for binding. Interestingly, the extent of competition by unlabeled m9, m11, m12, m14, m18 and m19 oligonucleotides seemed partial, and none by m10, m13, m15, m16 and m17 oligonucleotides. A brief summary of the mutagenesis scanning result is shown in Figure 5B. These data provide the first direct evidence that in human edn promoter, other than a conventional GA box located in a conserved -73/-66 region, there is a novel transcription regulatory motif in the conserved -62/-52 region.
###end p 30
###begin p 31
###xml 0 101 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of the putative regulatory elements for MAZ binding within the wild type 34-nt segment</bold>
###xml 256 258 256 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1133 1137 1132 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1443 1445 1442 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Identification of the putative regulatory elements for MAZ binding within the wild type 34-nt segment. (A) Identification of the MAZ-responsive core sequence. Scanning mutagenesis EMSA was used to define the binding site of the putative regulatory region. 32P-labeled wild type 34-nt segment was used for all experiments in the presence of 200-fold molar excess of unlabeled oligonucleotide competitor as indicated. The sequences of the mutant oligonucleotides m1 to m21 are shown in supplementary Table 2. (B) Summary of the DNA-binding activity of nuclear extract proteins to various mutant competitors to the wild type 34-nt segment. The stars above the sequence shown at the bottom indicate the nucleotides crucial for MAZ binding, and the dark circles below the sequence indicate the nucleotides that are less important for MAZ binding. (C) Western blot analysis of MAZ in nuclear extracts (50 mug protein) isolated from pcDNA3- and pcDNA3/MAZ-transfected HepG2 cells (lanes 1 and 2, respectively). (D) Nuclear extracts were prepared from HepG2 cells and incubated with biotinylated oligonucleotide from the 34-nt region of the edn promoter. The samples were separated by 8% SDS-PAGE and immunoblotted for MAZ. Relative densitometric quantitation of bands in lanes 1-5 are as follows: biotin control, wild type, mutant -62/-48, mutant -74/-65, mutant -62/-48 & -74/-65. The difference between the two groups is statistically significant (P < 0.05), as determined by the Wilcoxon Rank Sum test.
###end p 31
###begin p 32
###xml 35 44 35 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 118 124 <span type="species:ncbi:9986">rabbit</span>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 340 346 <span type="species:ncbi:9986">rabbit</span>
###xml 382 387 <span type="species:ncbi:9606">human</span>
In this study, we examined further in vitro MAZ binding to the 34-nt segment employing DAPA with anti-SAF-1 against a rabbit zinc finger protein serum amyloid A activating factor-1 (SAF-1) homologous to human MAZ [34]. We observed an enhanced MAZ signal was observed in the cells transfected with pcDNA3/MAZ (Fig. 5C), which indicated that rabbit anti-SAF-1 could be used to detect human MAZ in HepG2 cells. Furthermore, DAPA revealed that MAZ bound to the wild type 34-nt segment attached to the bead. However, the binding activity diminished when either the -74/-65 or -62/-48 region was mutated (Fig. 5D). These results were consistent with that of the EMSA scanning mutagenesis in which either the -74/-65 or -62/-48 mutation of the 34-nt segment led to decreased MAZ binding activity.
###end p 32
###begin title 33
Transcription factor Sp1 also binds to the 34-nt segment
###end title 33
###begin p 34
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1225 1229 1225 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
Our examination using TESS and Consite suggested that another transcription factor, Sp1, might also bind to the wild type 34-nt segment. Sp1 has also been shown earlier to recognize standard MAZ binding site, GA box [35,36]. In this study, as mentioned above, the Sp1 consensus oligonucleotide could compete with the 34-nt probe for binding to transcription factors in the HepG2 nuclear extract. With EMSA, we observed that low concentrations of Sp1 retarded the probe migration; while in the presence of a higher concentration of Sp1, higher mobility shift signals were observed (Fig. 6A). This phenomenon was consistent with previous reports that Sp1 readily forms a homo-oligomeric complex as concentration is increased [37]. Moreover, when HepG2 nuclear extract and biotin-labeled 34-nt probe were mixed following DAPA, Sp1 apparently bound to the wild type 34-nt oligonucleotide and the mutant-62/-48 oligonucleotide, but not to the mutant-74/-65 or double mutant oligonucleotide (Fig. 6B). A combination of approach with TESS and Consite predictions, EMSA, and DAPA allowed us to precisely map the Sp1 binding site at -74/-65, overlapping with the conventional GA box for MAZ binding within in the 34-nt segment of the edn promoter.
###end p 34
###begin p 35
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sp1 binding to the 34-nt segment <italic>in vitro</italic></bold>
###xml 134 136 134 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 696 698 696 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Sp1 binding to the 34-nt segment in vitro. (A) EMSA was performed in the presence of increasing amounts of recombinant Sp1 mixed with 32P-labeled oligonucleotide. (lane 1: 20 ng, lane 2: 30 ng, lane 3: 50 ng, lane 4: 100 ng, lane 5: 200 ng) (B) Nuclear extracts were prepared from HepG2 cells and incubated with biotinylated oligonucleotide derived from the 34-nt region of the edn promoter. The DAPA samples were separated by 8% SDS-PAGE and immunoblotted for Sp1. Relative densitometric quantitation of bands in lanes 1 to 5 are as follows: biotin control, wild type, mutant -62/-48, mutant -74/-65, mutant -62/-48 & -74/-65. The difference between the two groups is statistically significant (P < 0.05), as determined by the Wilcoxon Rank Sum test.
###end p 35
###begin title 36
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Competitive binding of Sp1 and MAZ in vitro
###end title 36
###begin p 37
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
As aforementioned, we have evidently shown that either Sp1 or MAZ binds to the GA box within the 34-nt oligonucleotide. It is possible that Sp1 and MAZ may antagonize each other and compete for GA box binding. To further investigate the competitive binding the GA box region and MAZ as well as Sp1, we performed EMSA experiments using recombinant between GST-MAZ and Sp1. We combined radiolabeled wild type probe with increasing concentrations of GST-MAZ in the presence of a fixed amount of Sp1. Both MAZ and Sp1 formed a single, distinct protein-DNA complex with wild type probe. As the relative ratio of MAZ over Sp1 exceed 500 ng, the amount of MAZ-DNA complex gradually increased, whereas that of Sp1-DNA complex drastically diminished. On the country, as the relative ratio of Sp1 over GST-MAZ that increased up to 20 ng, the amount of Sp1-DNA complex evidently increased, while the amount of MAZ-DNA complex dramatically declined. (Fig. 7B) Thus, we have clearly demonstrated the interplay between MAZ and Sp1 in terms of competition for the same binding site located in the 34-nt segment.
###end p 37
###begin p 38
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sp1 and MAZ competition for the same binding site within the 34-nt oligonucleotide <italic>in vitro</italic></bold>
Sp1 and MAZ competition for the same binding site within the 34-nt oligonucleotide in vitro. (A) Autoradiograms from EMSA using a constant amount of Sp1 protein and increasing quantities of GST-MAZ protein. (B) Autoradiograms from EMSA using a constant amount of GST-MAZ protein and increasing quantities of Sp1 protein. The lower panels show quantitation of the bands in each fraction.
###end p 38
###begin title 39
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Sp1 and MAZ bind to the edn promoter in vivo
###end title 39
###begin p 40
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 132 141 132 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 519 526 519 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 305 310 <span type="species:ncbi:9606">human</span>
While direct binding between MAZ or Sp1 and the 34-nt sequence stretch of the human edn promoter was verified by the abovementioned in vitro experiments, physical evidence for such interaction in vivo is further studied. With chromatin immunoprecipitation (ChIP), we observed that the 34-nt region of the human edn promoter could be pulled down by anti-Sp1 but not preimmune antibody (Fig. 8A), This observation lends credence to the conclusion that endogenous Sp1 indeed binds to the edn promoter at a specific region in vivo.
###end p 40
###begin p 41
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Binding of Sp1 and MAZ to the 34-nt region in the <italic>edn </italic>promoter <italic>in vivo</italic></bold>
Binding of Sp1 and MAZ to the 34-nt region in the edn promoter in vivo. (A) Cells were fixed by 1% formaldehyde, and the genomic DNA was sonicated until the size was approximately 1000 bp. The samples were then analyzed by the ChIP assay for Sp1, using IgG as a negative control. The samples were subjected to 30 cycles of PCR and separated on a 2% agarose gel. (B) ChAP assays were performed using HepG2 cells transfected with pcDNA3/MAZ-6H, pcDNA3/MAZDeltaF34-6H, or empty pcDNA plasmid. Two days after transfection, cells were scraped, cross-linked and sonicated, and the DNA-protein complexes were incubated with nickel resin slurry for 1 hr at 4degreesC. The affinity precipitated DNA/protein complexes were eluted by 1 M imidazole and subjected PCR amplification. Input DNA served as a positive control.
###end p 41
###begin p 42
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 516 524 516 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 549 553 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 874 878 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 887 894 887 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 543 548 <span type="species:ncbi:9606">human</span>
###xml 868 873 <span type="species:ncbi:9606">human</span>
The available anti-MAZ could only recognize the DNA binding surface on MAZ such that it was not suitable for use in the ChIP assay. To overcome this problem, we developed a ChAP assay that did not require an antibody. For this assay, pcDNA/MAZ-6H was transiently transfected into HepG2 cells, and soluble chromatin was generated by sonication. The MAZ-bound chromatin was pulled down by nickel resin, and the DNA was amplified by PCR with edn promoter-specific primers. As expected, our modified method demonstrated in vivo MAZ binding to the human edn promoter (Fig. 8B). Moreover, the binding activity was dramatically reduced when mutant MAZ lacking of the DNA binding domain was transfected. As a control, non-specific binding was not detected when only the pcDNA was transfected into the HepG2 cells. Our results clearly support that both Sp1 and MAZ bind to the human edn promoter in vivo.
###end p 42
###begin title 43
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Sp1 and MAZ differentially regulate edn promoter activity in vivo
###end title 43
###begin p 44
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 349 352 349 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 372 376 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 539 541 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 567 571 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 701 705 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 773 775 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9B</xref>
###xml 897 901 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 974 976 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1050 1054 1042 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1126 1134 1118 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1150 1154 1142 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
To distinguish the functions of Sp1 and MAZ in transactivation of the edn promoter, the reporter constructs were used to transfect HepG2 cells in the presence or absence of Sp1- or MAZ-expression vector. Interestingly, edn promoter activity was significantly inhibited in the presence of ectopically expressed MAZ, whereas MAZ had no effect on pGL3-ednDelta(-81/-48), the edn promoter lacking the crucial 34-nt segment. As anticipated, the inhibitory effect diminished when functionally defective MAZ (MAZDeltaF34) was overexpressed (Fig. 9A). On the other hand, the edn promoter activity was increased significantly in the presence of ectopically expressed Sp1. Nevertheless, Sp1 did not enhance the edn promoter activity in the absence of the critical 34-nt region (Fig. 9B). Our results strongly suggest that MAZ and Sp1 serve respectively as a repressor and an activator, in the regulation of edn transcription through interaction with the 34-nt sequence motif. In Fig. 2C above, we showed that deletion of the 34-nt region resulted in decreased edn promoter activity. We surmise that Sp1 binds mainly to the 34-nt region in vivo transactivating edn expression.
###end p 44
###begin p 45
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Differential regulatory roles of MAZ and Sp1 on transactivation through binding to the 34-nt sequence motif of the <italic>edn </italic>promoter</bold>
###xml 664 668 656 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
Differential regulatory roles of MAZ and Sp1 on transactivation through binding to the 34-nt sequence motif of the edn promoter. (A) Cotransfections and luciferase assays were performed with HepG2 cells in the presence of pcDNA3, pcDNA3/MAZ or pcDNA3/MAZDeltaF34. (B) Similar to (A), but cotransfection was performed with pcDNA3 or pcDNA3/Sp1. (C) Cells were transfected with 40 pmol/well Sp1/RNAi1, Sp1/RNAi2, or RNAi control. Forty-eight hours later, cells were harvested and protein lysates were separated by 8% SDS-PAGE and transferred to a PVDF membrane that was probed for Sp1 or actin. (D) Cotransfections and luciferase assays using wt and Delta (-81/-48) edn promoter constructs were carried out with HepG2 cells in the presence of control RNAi, Sp1/RNAi1 or Sp1/RNAi2. The difference between the two groups is statistically.
###end p 45
###begin p 46
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sp1 </italic>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 635 637 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9D</xref>
###xml 709 713 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 824 828 821 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 232 237 <span type="species:ncbi:9606">human</span>
To further demonstrate the critical role that Sp1 plays in edn promoter activity, RNAi was used to deplete endogenous Sp1 in HepG2 cells. Two sets of double-stranded RNA oligonucleotides (Sp1/RNAi-1 and Sp1/RNAi-2) corresponding to human Sp1 were separately transfected into HepG2 cells. Western blot analysis of cell lysates collected 72 hrs after transfection revealed that both Sp1/RNAi-1 and Sp1/RNAi-2 effectively depleted endogenous Sp1 protein (Fig. 9C). As a control, beta-actin was unaffected by RNAi treatment, indicating the specificity of the RNAi effect and that equivalent amounts of protein were loaded on the gel. Fig. 9D showed that cotransfection with Sp1/RNAi-1 or Sp1/RNAi-2 decreased the edn promoter activity to 40% and 50% relative to control, respectively. When the 34-nt region was deleted from the edn promoter, the effect of RNA interference on Sp1 was less apparent.
###end p 46
###begin p 47
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 177 184 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnases </italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 103 108 <span type="species:ncbi:9606">human</span>
Taken together, our results demonstrate that the regulatory roles of MAZ and Sp1 on transactivation of human edn govern the differential expression of the duplicated eosinophil rnases and that binding between these transcription factors and the 34-nt region in the edn promoter determines its expression.
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 5 9 5 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 505 509 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
Both edn and ecp have been postulated to have emerged from a gene duplication event after divergence of Old World and New World monkeys, as well as the most rapidly evolving coding sequences of primate ribonuclease genes. Variance in their promoter sequences may imply that another key deletion or insertion event occurred before the separation of hominoids and Old World monkeys [4]. Our observations as indicated in the putative phylogenic tree of the promoter regions of representative primate edn and ecp promoters (Fig. 1B and 1C) led to a hypothesis that deletion of the 34-nt sequence stretch might have occurred in the lineage of Old World Monkey and Hominoid.
###end p 49
###begin p 50
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 651 655 651 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 776 780 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 906 910 906 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 965 969 965 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1051 1055 1051 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1103 1107 1103 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 1177 1181 1177 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1185 1189 1185 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1321 1325 1321 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1329 1333 1329 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1359 1360 1359 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1516 1518 1516 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1528 1530 1528 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1567 1571 1567 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1669 1673 1669 1673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 1770 1774 1770 1774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 1171 1176 <span type="species:ncbi:9606">human</span>
###xml 1315 1320 <span type="species:ncbi:9606">human</span>
The upstream 1-kb sequences between human edn and ecp share 92% pairwise identity, but a major difference lies within a 34-nt (-81/-48) region, which was present in all the primate edn promoters we studied. Interestingly, we discovered that this characteristic 34-nt motif also is in the ecp promoter derived from macaque, an Old World Monkey. Based on the phylogenic tree of edn and ecp promoter sequences generated by the maximum parsimony method, a deletion of the unique 34-nt sequence stretch was proposed to occur in the lineage of Old World Monkeys and Hominoids. We showed further by transcriptional activity assays that expression of edn and ecp in HepG2 cells were positively correlated with the presence of the critical 34-nt segment. Transcription activity of the ecp promoter increased as a result of insertion of the 34-nt segment, but remained significantly lower than that of the wild type edn promoter. Furthermore, transcriptional activity of the edn promoter with deletion of the 34-nt segment was higher than that of the wild type ecp promoter. Thus, we speculate that other crucial cis transcription elements located in the divergent regions between human ecp and edn promoters may exist. Besides the 34-nt region of interest, BLAST analysis identified six additional divergent regions between human ecp and edn promoter sequences (Table 1). It may be worthwhile to further investigate the regulatory roles of these short motifs. It should be noted that some transcription factors such as PU.1 [26], C/EBP [22] have been characterized to enhance edn transcriptional activity. It is thus reasonable to speculate that PU.1 and C/EBP can also enhance ecp promoter activity based on the sequence indentity of the correspondent transcription elements in ecp promoter.
###end p 50
###begin p 51
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
Minor divergent segments upstream of the translation start site of edn and ecp
###end p 51
###begin p 52
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
The characteristic 34-nt sequence motif in the edn promoter enhanced the transcriptional activity in HepG2 (Fig. 2) as well as HL-60 clone 15 cells (Supplementary Fig. 1). EMSA with HepG2 nuclear extracts and 34-nt promoter probe revealed specific mobility shift patterns, suggesting that the 34-nt segment contains a region essential for transactivation of edn in HepG2 cells. When HepG2 nuclear extract bound to the wild type 34-nt probe, excess unlabeled wild type oligonucleotide, but not oligonucleotides containing site-specific mutations at -74/-65 or -62/-48, competed effectively for binding to the nuclear proteins. Thus, both conserved regions -74/-65 and -62/-48 were associated with the transcription factors, and elevation of the transcriptional activity in the cells was also verified by the reporter assay.
###end p 52
###begin p 53
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD4 </italic>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAG-1</italic>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 423 424 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT</italic>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 530 533 530 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOS</italic>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p21 </italic>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1441 1442 1441 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1595 1597 1595 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1709 1711 1709 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1712 1714 1712 1714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1715 1717 1715 1717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1718 1720 1718 1720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1721 1723 1721 1723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1846 1848 1846 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1963 1967 1963 1967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 2076 2080 2076 2080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 2104 2112 2104 2112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 2118 2120 2118 2120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 117 123 <span type="species:ncbi:9986">rabbit</span>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
###xml 2070 2075 <span type="species:ncbi:9606">human</span>
MAZ is a transcriptional factor with six zinc fingers that bind to a GA box (GGGAGGG) at the ME1a1 site [33,38]. Its rabbit and mouse homologs are identified as SAF-1 [34] and Pur-1, respectively. MAZ has also been shown to bind the upstream regions of various genes, including CD4 [39], NMDA receptor subunit type I [40], recombination activating gene-1 (RAG-1) [41], PTH-related peptide receptor [36], phenylethanolamine N-methyltransferase (PNMT) [42], serotonin 1a receptor [43], insulin I and II [44], nitric oxide synthase (NOS) [45] and p21 [46], and also is involved in RNA polymerase II termination [47] and adenovirus major late promoter activation [48]. Our study has advanced further that MAZ binds the 34-nt region through the third and fourth zinc fingers, extending its effects on transcriptional activity. We were surprised that unlabeled EMSA competitors m10 to m17 did not appreciably compete the major band shift even though these competitors all contained the full-length GA box believed to be tightly bound by MAZ. Comprehensive EMSA scanning mutagenesis revealed that MAZ bound not only to the known GA box but also to another conserved site, CTCTGCTG, an apparently novel transcription factor binding motif. Thus, we postulate that some other cofactor protein(s) may bind to the CTCTGCTG motif to further enhance MAZ binding, and thus mutations at any position in this novel motif leads to decreased MAZ binding (Fig. 5). Interestingly, even in the absence of another protein(s), MAZ alone had strong binding activity because GST-MAZ bound the wild type 34-nt probe (Fig. 4B). Notably, MAZ always cooperates with another transcription factor, such as Sp1, to control promoter activity [35,42,43,49,50]. The discovery of two sites critical for MAZ binding is consistent with our luciferase assay results. As shown in Figure 2C, mutation in either the -74/-65 or -62/-48 region led to reduced luciferase activity almost equal to that of pGL3-edn without the 34-nt region. Furthermore, the ChAP assay showed that MAZ bound to the 34-nt region of the human edn promoter in HepG2 cells in vivo (Fig. 7C).
###end p 53
###begin p 54
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 81 89 81 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 297 300 297 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NOS</italic>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT</italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
In addition to MAZ, the transcription factor Sp1 also bound the GA box (Fig. 6). In vivo Sp1 binding to the 34-nt sequence was also demonstrated by ChIP assay (Fig. 7A). Sp1 preferentially recognizes a guanidine nucleotide-rich sequence. [51] MAZ and Sp1 cooperatively regulate many genes such as NOS, PNMT, and those encoding serotonin 1a receptor and parathyroid hormone [42,43,45,52]. Most studies report the binding site for MAZ near or partially overlapping that of Sp1.
###end p 54
###begin p 55
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 403 407 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 683 686 683 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 771 776 771 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
In our study using HepG2 cells, cotransfection with MAZ DNA and reporter plasmid containing the edn promoter revealed that MAZ functioned as a repressor with respect to regulation of transcriptional activity in the presence of the 34-nt sequence region. Such repression effect was reversed when the 34-nt segment was removed, indicating that the 34-nt region served as the MAZ-responsive element in the edn promoter (Fig. 8A). In contrast, Sp1 is considered to play a role as an activator based on the observation derived from cotransfection with Sp1 DNA and the reporter plasmid containing the edn promoter (Fig. 8B). Previous studies have shown that MAZ and Sp1 recognize the same cis-elements in promoters and thereby regulate gene expression independently [35]. Song et al. have found that MAZ and Sp1 associate with histone deacetylase and DNA methyltransferase, respectively, to regulate transcriptional activity [35].
###end p 55
###begin title 56
Conclusion
###end title 56
###begin p 57
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 542 546 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 570 577 570 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 749 753 749 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 801 805 801 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 934 938 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 408 413 <span type="species:ncbi:9606">human</span>
In conclusion, we characterized the presence of an evolutionarily conserved 34-bp sequence in all primate genes encoding eosinophil-derived neurotoxin (edn) genes and only one gene encoding eosinophil cationic protein (ecp). Given the fact that primate edn and ecp are known to be products of gene duplication event,such a conserved 34-bp sequence motif constituted a region essential for transactivation of human edn in hepatocellular carcinoma cells. Our findings indicate that Sp1 as well as MAZ constitutively bind at 34-nt region of the edn promoter in HepG2 cells in vivo, and that the activity of the promoter primarily depends on competition between Sp1 and MAZ. Furthermore, our data reveal that Sp1 binds at the 34-nt region and activates edn gene expression, on the contrary, MAZ represses edn gene expression upon binding to the 34-nt region. The underlying molecular mechanisms about Sp1 and MAZ cooperation in governing edn promoter activity still remain to be further investigation.
###end p 57
###begin title 58
Methods
###end title 58
###begin title 59
Cell culture and transient transfection
###end title 59
###begin p 60
###xml 40 56 40 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saimiri sciureus</italic>
###xml 58 77 58 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Macaca fascicularis</italic>
###xml 79 93 79 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pongo pygmaeus</italic>
###xml 95 111 95 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gorilla gorilla </italic>
###xml 115 131 115 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pan troglodytes </italic>
###xml 656 657 652 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 685 686 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 872 876 868 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 977 979 965 967 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 40 56 <span type="species:ncbi:9521">Saimiri sciureus</span>
###xml 58 77 <span type="species:ncbi:9541">Macaca fascicularis</span>
###xml 79 93 <span type="species:ncbi:9600">Pongo pygmaeus</span>
###xml 95 110 <span type="species:ncbi:9593">Gorilla gorilla</span>
###xml 115 130 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 414 418 <span type="species:ncbi:9913">calf</span>
###xml 611 617 <span type="species:ncbi:9913">bovine</span>
Cells from non-human primates including Saimiri sciureus, Macaca fascicularis, Pongo pygmaeus, Gorilla gorilla and Pan troglodytes were purchased from Coriell Institute for Medical Research and their cultures maintained at Dr. Chung-I Wu's Laboratory (University of Chicago). All non-human primate cell cultures were maintained in alpha-modified minimum essential medium (alpha-MEM) plus 10% non-inactivated fetal calf serum (FCS). HepG2 cells were cultured in DMEM medium (Sigma) containing 10% heat-inactivated FCS. HL-60 clone 15 promyelocytic leukemia cells were cultured in RPMI-1640 medium with 10% fetal bovine serum supplemented with 25 mM HEPPSO (N-[2-hydroxyethyl]piperazine-N-[2-hydroxy-propanesulfonic acid] (Sigma), and maintained at pH 7.6. Exponentially growing cells at 95% confluence were trypsinized prior to genomic DNA purification employing the Wizard(R) Genomic DNA purification kit (Promega). All cells were cultured in a 37degreesC incubator under 5% CO2 in air. For transient transfections, the HepG2 and HL-60 clone 15 cell lines were treated with Transfast (Promega) and electroporation, respectively, according to the manufacturer's instructions.
###end p 60
###begin p 61
###xml 83 86 <span type="species:ncbi:9685">cat</span>
RNA interference (RNAi) duplexes directed against Sp1 and irrelevant control RNAi (cat. no: 12935-100) were purchased from Invitrogen Life Technologies. The two targeted sequences used to silence Sp1 were 5'-GCAGACACAGCAGCAACAAAUUCUU-3' and 5'-GGAACAUCACCUUGCUACCUGUCAA-3'. Each RNAi was separately transfected into target cells using Lipofectamine 2000 according to the manufacturer's instructions (Invitrogen Life Technologies).
###end p 61
###begin title 62
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
Amplification of Upstream Regions of Primate edn and ecp
###end title 62
###begin p 63
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 596 600 572 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 715 719 689 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 130 135 <span type="species:ncbi:9606">human</span>
The primer sets, #1/#2 and #3/#4, were designed based on sequences of the first exon and the upstream region of the corresponding human edn and ecp to amplify approximately 1-kb upstream fragments from the transcription start sites, respectively (Supplementary Table 1). Polymerase chain reaction (PCR) was conducted at 95degreesC for 5 min followed by 30 cycles of 95degreesC for 30 sec, 55degreesC for 30 sec, and 72degreesC for 90 sec. The desired fragments were purified and cloned into pGEM-T easy vector (Promega). The sequences were confirmed using automated DNA sequencing with the BigDye(R) Terminator V3.1 Cycle Sequencing kit (Applied Biosystems), and the reaction products were analyzed with a ABI PRISM(R) 3100 Genetic Analyzer.
###end p 63
###begin title 64
Plasmid construction
###end title 64
###begin p 65
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 227 230 227 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 266 270 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 394 398 394 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 146 151 <span type="species:ncbi:9606">human</span>
The fragments of human edn and ecp promoters from nucleotides -1,000 to +297 were amplified using primer sets #5/#6 and #7/#8, respectively, from human genomic DNA to generate the luciferase reporter plasmids pGL3-edn and pGL3-ecp. The transcriptional start site of edn previously defined by Tiffany HL et al [27] to be located 23 nucleotides 3' from a consensus TATA box was used. That of the ecp was assumed to be at the correspondent site.
###end p 65
###begin p 66
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 54 57 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 73 76 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 95 98 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
###xml 459 462 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dpn</italic>
###xml 496 504 468 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 524 528 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 532 536 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 496 503 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
For mutant reporter plasmids, the edn Delta(-81/-48), edn-mut (-74/-65), edn-mut (-62/-48) and ecp+(-81/-48) were generated using primer sets #9/#10, #11/#12, #13/#14, #15/#16, respectively, by Quik-Change Site-Directed Mutagenesis (Stratagene). The reactions were conducted at 95degreesC for 5 min followed by 20 cycles of 95degreesC for 30 sec, 55degreesC for 30 sec and 72degreesC for 12 min. After PCR amplification, the products were treated with 2 U of DpnI and separately transformed into E. coli Top10F'. The mutant edn and ecp promoter sequences were confirmed by DNA sequencing.
###end p 66
###begin p 67
###xml 319 324 <span type="species:ncbi:9606">Human</span>
The pGEX/MAZ and pGEX/MAZDeltaF34 expression plasmids were kindly provided by Dr. Kazunari K. Yokoyama (Gene Engineering Division, Bioresource Center, Tsukuba Institute, RIKEN, 3-1-1 Koyadai, Tsukuba, Ibaraki 305-0074, Japan). The Sp1 expression plasmid, pcDNA3/Sp1, was obtained from Dr. Jacob Bar-Tana (Department of Human Nutrition and Metabolism, Hebrew University Medical School, Jerusalem, P.O.). The inserts of pGEX/MAZ and pGEX/MAZDeltaF34 were subcloned into pcDNA3 (Invitrogen Life Technologies) to generate pcDNA3/MAZ-6H and pcDNA3/MAZDeltaF34-6H. The sequences of each recombinant clone were determined by automated DNA sequencing.
###end p 67
###begin title 68
Development of multiple indexing sequence alignment
###end title 68
###begin p 69
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1517 1519 1517 1519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 1559 1561 1559 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k </italic>
###xml 1625 1626 1625 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1751 1753 1751 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1936 1943 1936 1943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rnases </italic>
###xml 1962 1966 1962 1966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 1975 1979 1975 1979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
A novel method of MISA based on interval-jumping searching algorithms and dynamic programming techniques was developed to identify characteristic features among the query sequences [53,54]. The block-based pattern searching algorithms were designed to find short consensus motifs by a combination of hash encoding, quick sorting and interval-jumping techniques; this was to avoid unnecessary comparisons and to achieve approximate matching functions. In this module, each possible subsegment of the imported sequences was considered as a fundamental element, and its contents are encoded as a unique digital number and allocated in a corresponding interval for the following matching procedures. Due to the unique transformation and exact reconvertible features, the encoded numbers could be efficiently matched in an ordered and well-defined interval. According to a variable combination of parameter settings, we were able to identify the consensus motifs with different properties of pattern lengths, tolerance conditions, and occurrence frequencies and label each of the sequences. Once the consensus motifs were completely searched, a scoring matrix of pairwise distant measurements is constructed to select a referred indexed sequence prior to the multiple alignment procedures. The MISA algorithms are then implemented by performing dynamic programming and merging processing in accordance with the assigned reference sequence based on the indexed fundamental elements instead of single residues. If there are k indexed sequences under evaluation, the k pairwise alignments are further combined and transformed into a k-row multiple alignment indexing matrix through a multiple merging process obeying the principle "once a gap, always a gap" [55]. Finally, the aligned overlapped consensus labels were combined as a representative segment to visually display the identified combinatorial patterns. To analyze primate eosinophil rnases in this paper, six edn and five ecp promoter sequences of approximately 1 kb length in FASTA format were input into MISA. Various combinations of fundamental pattern length, number of tolerant residues, and occurrence rate were set to scan along the full-length promoter sequences, and the results showed consistent performance for the conserved regions as well as the dominant portions of variation labeled in color-coded bars and dotted grey grids, respectively.
###end p 69
###begin title 70
Phylogenetic analysis of DNA sequences
###end title 70
###begin p 71
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 323 342 323 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. fascicularis edn</italic>
###xml 343 358 343 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. pygmaeus edn</italic>
###xml 360 374 360 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G. gorilla edn</italic>
###xml 376 394 376 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. troglodytes edn</italic>
###xml 396 410 396 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. sapiens edn</italic>
###xml 412 431 412 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. fascicularis ecp</italic>
###xml 433 448 433 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. pygmaeus ecp</italic>
###xml 450 464 450 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G. gorilla ecp</italic>
###xml 466 484 466 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. troglodytes ecp</italic>
###xml 490 505 490 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. sapiens ecp </italic>
###xml 323 338 <span type="species:ncbi:9541">M. fascicularis</span>
###xml 343 354 <span type="species:ncbi:9600">P. pygmaeus</span>
###xml 360 370 <span type="species:ncbi:9593">G. gorilla</span>
###xml 376 390 <span type="species:ncbi:9598">P. troglodytes</span>
###xml 396 406 <span type="species:ncbi:9606">H. sapiens</span>
###xml 412 427 <span type="species:ncbi:9541">M. fascicularis</span>
###xml 433 444 <span type="species:ncbi:9600">P. pygmaeus</span>
###xml 450 460 <span type="species:ncbi:9593">G. gorilla</span>
###xml 466 480 <span type="species:ncbi:9598">P. troglodytes</span>
###xml 490 500 <span type="species:ncbi:9606">H. sapiens</span>
Primate ecp and edn promoter sequences were aligned using MEGA 3.1 software. Phylogenetic trees were generated by the neighbor joining method with bootstrap resampling (data resampled 100 times) to assess the degree of support for the phylogenic branching indicated by the optimal tree. The exact numbers of nucleotides of M. fascicularis edn,P. pygmaeus edn, G. gorilla edn, P. troglodytes edn, H. sapiens edn, M. fascicularis ecp, P. pygmaeus ecp, G. gorilla ecp, P. troglodytes ecp, and H. sapiens ecp used for analysis were respectively 921 bp, 923 bp, 921 bp, 921 bp, 921 bp, 931 bp, 883 bp, 887 bp, 887 bp, and 887 bp.
###end p 71
###begin title 72
RNA isolation and RT-PCR
###end title 72
###begin p 73
###xml 753 756 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 818 821 801 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp</italic>
Total RNAs of HepG2 and HL-60 clone 15 cells were isolated by Trizol Reagent (Gibco) and the contaminant genomic DNA was further digested by RNase-free DNaseI (Promega). Two micrograms of total RNA and 0.5 mug oligo-dT were added in a sterile RNase-free microcentrifuge tube, heated at 70degreesC for 5 min to melt secondary structure within the template. A mixture containing 5 mul M-MLV 5x Reaction buffer (Promega), 1.25 mul 10 mM dNTP, 1 mul recombinant RNasin rib nuclease inhibitor (Promega), M-MLV RTase (Promega), and nuclease-free water were added to a final volume of 25 mul. The reverse transcription reaction was performed at 42degreesC for 1 hr in a thermal cycler (ASTEC, PC808). For each reaction, 5 nmole of forward and reverse primers (edn: 5'-CTCACTCCATGTCAAACCT-3', 5'-GCCGTTGATAATTGTTAAGGA-3', and ecp: 5'-TATGCAGACAGACCAGGATGG-3' and 5'-GGAACCACAGGATACCGTGGAGAA-3') and 80 ng cDNA were incubated with 1.25 units of Ex Taqtrade mark (Takara), 6.25 nmole dNTPs and Ex Taqtrade mark polymerase buffer. The PCR products were electrophoresed on a 2.0% agarose gel and stained with ethidium bromide.
###end p 73
###begin title 74
Promoter activity assays
###end title 74
###begin p 75
###xml 64 67 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn</italic>
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
###xml 220 222 220 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 516 524 510 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla </italic>
After forty-eight hours transfection with individual pGL3, pGL3-edn, pGL3-ecp reporter plasmids, the cells were washed twice with PBS and lysed by Passive Lysis Buffer (Promega). The lysates were centrifuged at 16,500 x g for 1 min at 4degreesC, and the supernatant was collected. The firefly and Renilla luciferase activities were measured by TD-20/20 luminometer (Victor), and the relative activity was calculated by simply dividing luminescence intensity obtained from the assay for firefly luciferase by that of Renilla luciferase.
###end p 75
###begin title 76
Preparation of nuclear extract
###end title 76
###begin p 77
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 353 355 351 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 645 647 636 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
###xml 886 892 <span type="species:ncbi:9913">bovine</span>
Nuclear extracts were prepared by NE-PER nuclear extraction kit (Pierce). In brief, about 5 x 107 HepG2 cells were trypsinized, collected and suspended in 200 mul CER I buffer and incubated for 10 min on ice. After 11 mul CER II was added and incubated for 1 min on ice, the cytoplasmic and nuclear extracts were separated by centrifugation at 16,500 x g for 5 min at 4degreesC. Cytoplasmic extracts in the supernatant fraction were transferred into a clean microcentrifuge tube, whereas the pellets were resuspended by adding 100 mul ice-cold NER and the mixture was incubated for 40 min on ice. The mixture was finally centrifuged at 16,500 x g for 10 min at 4degreesC. Nuclear extracts in the supernatant fraction were transferred into a clean microcentrifuge tube and stored at -80degreesC until use. Concentrations of proteins in lysates were determined with BCA kit (Pierce) with bovine serum albumin (fraction V) as the standard.
###end p 77
###begin title 78
Electrophoretic mobility shift assays (EMSA)
###end title 78
###begin p 79
###xml 83 84 83 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 430 434 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 549 551 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 724 726 702 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 842 843 818 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 424 429 <span type="species:ncbi:9606">human</span>
The oligonucleotide sequences used in this study are listed in supplementary Table 2. DNA annealing was performed by heating 10 muM of each complementary strand of the oligonucleotide to 95degreesC for 10 min, followed by cooling gradually to 25degreesC over a period of three hours. The oligonucleotides corresponding to wild type and mutant 34-nt segments were separately synthesized to span the -86 and -48 region of the human edn promoter. The wild type probe used for EMSA was end-labeled by incubation with T4 polynucleotide kinase and [gamma-32P]ATP. The labeled probes were then individually purified by passing through a Sephadex G-25 spin column (GE Healthcare). Binding reactions were conducted with 1 mul [gamma-32P]-labeled probe, 20 mug nuclear extract protein, 1 mug poly (dI-dC), 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 5 mM MgCl2, 1 mM EDTA, and 10% glycerol in a total volume of 20 mul, and the reactions were incubated at 30degreesC for 30 min. For competition experiments, the nuclear extracts were carried out with a 200-fold molar excess of double-stranded competitor oligonucleotide at 30degreesC for 30 min prior to the addition of radiolabeled probes. To identify the transcription factors constituting in the protein-DNA binding complexes, anti-Sp1 (PEP2, Santa Cruz Biotechnology) or anti-MAZ (Dr. Kenneth Marcu, State University of New York, Stonybrook, NY) was included in the binding reactions. The protein-DNA complexes were resolved by 6% non-denaturing polyacrylamide gel electrophoresis using 45 mM Tris, 45 mM boric acid, and 1 mM EDTA (pH 8.3). The gel was dried and exposed to X-ray film at -70degreesC using an intensifying screen.
###end p 79
###begin title 80
Expression and purification of GST fusion proteins
###end title 80
###begin p 81
###xml 51 59 47 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 51 63 <span type="species:ncbi:511693">E. coli BL21</span>
pGEX/MAZ and pGEX/MAZDeltaF34 were introduced into E. coli BL21 (DE3), and synthesis of each fusion protein was induced by addition of 0.5 mM isopropylb-d-thiogalactopyranoside to the LB culture medium. Proteins were purified with glutathione-agarose beads according to the manufacturer's protocol (GE Healthcare).
###end p 81
###begin title 82
DNA affinity precipitation assay (DAPA)
###end title 82
###begin p 83
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 433 434 425 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 435 436 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 438 439 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
The oligonucleotide corresponding to -84 to -48 bp within the edn promoter as well as mutant oligonucleotides were individually biotinylated at the 5'-terminus and then annealed with their complementary strands. All reactions were carried out at 4degreesC with gentle rocking unless otherwise noted. DAPA was performed by incubating 400 mug of nuclear extract with 20 mug poly (dI-dC) in binding buffer (20 mM HEPES pH 7.6, 10 mM (NH4)2SO4, 1 mM EDTA, 1 mM dithiothreitol, 1% (w/v) Tween 20, 100 mM KCl) that was pre-cleaned with 50 mul streptavidin-agarose beads (GE Healthcare) for 1 hr, and then the supernatant was incubated with 2 mug of biotinylated DNA oligonucleotide for 4 hr or overnight. The protein-DNA complexes were incubated with 20 mul streptavidin-agarose beads for 1 hr prior to collection and washed five times with binding buffer containing 0.5% (w/v) Nonidet P-40. Sample buffer (2x) was added to the streptavidin-precipitated DNA-protein complex and subsequently boiled for 10 min. The proteins were resolved by 10% SDS-polyacrylamide gel electrophoresis followed by western blot detection with specific antibodies.
###end p 83
###begin title 84
Chromatin immunoprecipitation assay (ChIP)
###end title 84
###begin p 85
The ChIP assay kit and anti-Sp1 were purchased from Upstate Biotechnologies and used according to the manufacturer's instructions. Immunoprecipitations were performed at 4degreesC overnight with 5 mug primary antibody. Immune complexes were harvested with protein A-Sepharose beads (60 mul/precipitation) as described. Following immunoprecipitation, washing, and purification of DNA, the samples were dissolved in water and used as templates for PCR amplification using two primers: 5'-AAGTGGACTATGTACCAAT-3' and 5'-GGAACTGTTTAAATAAAGCA-3' to generate a 108-bp fragment. The reactions were conducted at 95degreesC for 5 min followed by 28 cycles of 95degreesC for 30 sec, 60degreesC for 30 sec and 72degreesC for 15 sec.
###end p 85
###begin title 86
Chromatin affinity precipitation assay (ChAP)
###end title 86
###begin p 87
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 446 448 440 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g </italic>
An expression plasmid for His-tagged full-length MAZ, pcDNA3/MAZ-6H was transiently transfected into HepG2 cells. Two days after transfection, cells (1 x 107) were cross-linked with 1% formaldehyde in PBS for 10 min at 30degreesC. The treated cells were washed two times with ice-cold PBS, and the cell lysate was then collected with lysis buffer. The chromatin was fragmented by sonication to an average size of 1 kb and centrifuged at 16,000 x g at 4degreesC for 10 min. The supernatant was diluted fivefold with 1x binding buffer (500 mM NaCl, 20 mM Tris-HCl, pH 7.9) containing protease inhibitors and mixed well with 50 mul salmon sperm DNA-saturated nickel resin slurry (GE Healthcare) for 1 hr. The resin was precipitated followed by washing two times with 1 ml binding buffer and two times with 1 ml wash buffer (50 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.9). Protein-DNA complexes were eluted from the His-binding resin with 100 mul of elution buffer (1 M imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.9) two times. The protein-DNA crosslinks were reversed by heating at 65degreesC overnight, and proteins were digested with proteinase K (0.5 mg/ml) at 55degreesC for 1 hr. DNA was purified by phenol-chloroform extraction and ethanol precipitation. DNA from the complexes was analyzed by PCR amplification using the same primer pair for ChIP assay.
###end p 87
###begin title 88
Western blotting
###end title 88
###begin p 89
After electrophoresis, the proteins were transferred onto a nitrocellulose membrane (GE Healthcare). The membrane was incubated in 3% BSA at 25degreesC for 1 hr prior to incubation overnight with anti-Sp1 or anti-SAF-1 (Dr. Alpana Ray, Department of Veterinary Pathobiology, University of Missouri, Columbia, MO), followed by secondary antibody HRP-conjugated IgG (1:5000, Jackson ImmunoResearch) for 2 hr. The target proteins were visualized by the ECL system (Pierce).
###end p 89
###begin title 90
Statistical analysis
###end title 90
###begin p 91
###xml 241 243 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
All experiments were performed at least three times, each in duplicate. The data are expressed as the means +/- S.E. For comparison, the data were analyzed using the Wilcoxon Rank Sum test. The cutoff for statistical significance was set as P < 0.05.
###end p 91
###begin title 92
Competing interests
###end title 92
###begin p 93
The author(s) declares that there are no competing interests.
###end p 93
###begin title 94
Authors' contributions
###end title 94
###begin p 95
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">edn </italic>
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ecp </italic>
H-YW (Graduate student) discovered and suggested the involvement of transcription factor MAZ in edn and ecp transcription, obtained all plasmids and antibodies used in this study from other research labs, worked out many experimental conditions such as EMSA using isotope labeling, ChIP, and ChAP, provided results for most of the figures and finalized the manuscript.
###end p 95
###begin p 96
H-TC, Ph.D. (Graduate student) worked out experimental conditions including cloning, DNA sequencing, selection of target host cells for transfection, cell culture and transient transfection, DAPA, provided multiple sequence analysis, crucial experimental data and figures, and participated in the preparation of this manuscript.
###end p 96
###begin p 97
T-WP, Ph.D. (Professor, co-PI) developed the multiple indexing sequence alignment (MISA) algorithm for multiple sequence analysis, provided target sequence motifs for biological manipulation, and participated in manuscript writing.
###end p 97
###begin p 98
C-IW, Ph.D. (Professor, consultant) suggested the use of representative primate cell lines for comparative studies, provided genomic DNAs for sequencing, and programs for phylogeny analysis, and participated in the discussion of the findings and the manuscript.
###end p 98
###begin p 99
Y-HL (Graduate student) constructed mutant promoter plasmids, EMSA probes, DAPA probes, experimentally confirmed the role of Sp1, provided experimental data for the current draft, and participated in manuscript writing.
###end p 99
###begin p 100
Y-HC (Graduate student) constructed most of the reporter plasmids, identified by experiments the role of Sp1, performed database analysis and transcription factor prediction, and participated in manuscript writing.
###end p 100
###begin p 101
H-LT (Graduate student) amplified and sequenced all cloned primate eosinophil rnase promoters, and performed initial database analysis.
###end p 101
###begin p 102
C-YT, Ph.D. (Professor and collaborator) implemented multiple sequence analysis and database searching algorithms, and participating in the discussion of the findings.
###end p 102
###begin p 103
W-YC (Graduate student) implemented MISA and participated in manuscript writing.
###end p 103
###begin title 104
Supplementary Material
###end title 104
###begin title 105
Additional file 1
###end title 105
###begin p 106
Click here for file
###end p 106
###begin title 107
Additional file 2
###end title 107
###begin p 108
Click here for file
###end p 108
###begin title 109
Additional file 3
###end title 109
###begin p 110
Click here for file
###end p 110
###begin title 111
Acknowledgements
###end title 111
###begin p 112
We thank Drs. P.-C. Huang, L.-Y. Lin, W.-G. Chou, H.-Y. Chang, C.-Y. Lan, W.-Y. Chow and Y.-K. Lai for their critical comments and discussions about this manuscript. This work was supported by research grants NSC 95-2627-B-007-003, VGHUST96-G2-02-1, and National Tsing Hua University Structural Proteomic Center for Drug Discovery grant 95N2517E1 to M. D.-T. Chang, NSC95-2221-E-019-032 and Center for Marine Bioscience and Biotechnology (CMBB), National Taiwan Ocean University grant to T.-W. Pai, and NSC 96-2752-B-007-003-PAE to Dr. Ping-Chiang Lyu.
###end p 112
###begin article-title 113
###xml 37 42 <span type="species:ncbi:9606">human</span>
Purification and characterization of human pancreatic ribonuclease
###end article-title 113
###begin article-title 114
###xml 21 26 <span type="species:ncbi:9606">human</span>
Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells
###end article-title 114
###begin article-title 115
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human eosinophil-derived neurotoxin and eosinophil protein X are likely the same protein
###end article-title 115
###begin article-title 116
Rapid evolution of a unique family of primate ribonuclease genes
###end article-title 116
###begin article-title 117
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human RNase 7: a new cationic ribonuclease of the RNase A superfamily
###end article-title 117
###begin article-title 118
The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories
###end article-title 118
###begin article-title 119
Membrane-bound carboxypeptidase E facilitates the entry of eosinophil cationic protein into neuroendocrine cells
###end article-title 119
###begin article-title 120
###xml 105 110 <span type="species:ncbi:9606">human</span>
Signal peptide of eosinophil cationic protein upregulates transforming growth factor-alpha expression in human cells
###end article-title 120
###begin article-title 121
Signal peptide of eosinophil cationic protein is toxic to cells lacking signal peptide peptidase
###end article-title 121
###begin article-title 122
###xml 48 53 <span type="species:ncbi:9606">human</span>
Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease
###end article-title 122
###begin article-title 123
###xml 34 39 <span type="species:ncbi:9606">human</span>
Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity
###end article-title 123
###begin article-title 124
###xml 62 67 <span type="species:ncbi:9606">human</span>
Purification and characterization of three ribonucleases from human kidney: comparison with urine ribonucleases
###end article-title 124
###begin article-title 125
###xml 45 50 <span type="species:ncbi:9606">human</span>
Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily
###end article-title 125
###begin article-title 126
RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta
###end article-title 126
###begin article-title 127
Gene duplication and nucleotide substitution in evolution
###end article-title 127
###begin article-title 128
The evolution of functionally novel proteins after gene duplication
###end article-title 128
###begin article-title 129
Gene duplication: past, present and future
###end article-title 129
###begin article-title 130
###xml 69 75 <span type="species:ncbi:9606">humans</span>
Sequence variation at two eosinophil-associated ribonuclease loci in humans
###end article-title 130
###begin article-title 131
###xml 4 9 <span type="species:ncbi:4932">yeast</span>
Two yeast acid phosphatase structural genes are the result of a tandem duplication and show different degrees of homology in their promoter and coding sequences
###end article-title 131
###begin article-title 132
###xml 4 7 <span type="species:ncbi:3888">pea</span>
The pea light-independent photomorphogenesis1 mutant results from partial duplication of COP1 generating an internal promoter and producing two distinct transcripts
###end article-title 132
###begin article-title 133
Splitting pairs: the diverging fates of duplicated genes
###end article-title 133
###begin article-title 134
###xml 79 84 <span type="species:ncbi:9606">human</span>
C/EBP regulates the promoter of the eosinophil-derived neurotoxin/RNS2 gene in human eosinophilic cells
###end article-title 134
###begin article-title 135
The promoter polymorphism in the eosinophil cationic protein gene and its influence on the serum eosinophil cationic protein level
###end article-title 135
###begin article-title 136
Intronic enhancer activity of the eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3) genes is mediated by an NFAT-1 consensus binding sequence
###end article-title 136
###begin article-title 137
Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1
###end article-title 137
###begin article-title 138
The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene
###end article-title 138
###begin article-title 139
Enhanced expression of the eosinophil-derived neurotoxin ribonuclease (RNS2) gene requires interaction between the promoter and intron
###end article-title 139
###begin article-title 140
###xml 76 82 <span type="species:ncbi:9606">humans</span>
Tissue-specific expression of pancreatic-type RNases and RNase inhibitor in humans
###end article-title 140
###begin article-title 141
ConSite: web-based prediction of regulatory elements using cross-species comparison
###end article-title 141
###begin article-title 142
TESS: Transcription Element Search Software on the WWW
###end article-title 142
###begin article-title 143
Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily
###end article-title 143
###begin article-title 144
Two consecutive zinc fingers in Sp1 and in MAZ are essential for interactions with cis-elements
###end article-title 144
###begin article-title 145
MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination
###end article-title 145
###begin article-title 146
Isolation and functional characterization of cDNA of serum amyloid A-activating factor that binds to the serum amyloid A promoter
###end article-title 146
###begin article-title 147
Independent repression of a GC-rich housekeeping gene by Sp1 and MAZ involves the same cis-elements
###end article-title 147
###begin article-title 148
###xml 68 73 <span type="species:ncbi:9606">human</span>
Functional importance of Myc-associated zinc finger protein for the human parathyroid hormone (PTH)/PTH-related peptide receptor-1 P2 promoter constitutive activity
###end article-title 148
###begin article-title 149
Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism
###end article-title 149
###begin article-title 150
Isolation of a novel cDNA encoding a zinc-finger protein that binds to two sites within the c-myc promoter
###end article-title 150
###begin article-title 151
A Myc-associated zinc finger protein binding site is one of four important functional regions in the CD4 promoter
###end article-title 151
###begin article-title 152
Effect of the ubiquitous transcription factors, SP1 and MAZ, on NMDA receptor subunit type 1 (NR1) expression during neuronal differentiation
###end article-title 152
###begin article-title 153
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
Activation of mouse RAG-2 promoter by Myc-associated zinc finger protein
###end article-title 153
###begin article-title 154
Phenylethanolamine N-methyltransferase gene expression. Sp1 and MAZ potential for tissue-specific expression
###end article-title 154
###begin article-title 155
The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1
###end article-title 155
###begin article-title 156
Pur-1, a zinc-finger protein that binds to purine-rich sequences, transactivates an insulin promoter in heterologous cells
###end article-title 156
###begin article-title 157
###xml 24 29 <span type="species:ncbi:9606">human</span>
Characterization of the human endothelial nitric-oxide synthase promoter
###end article-title 157
###begin article-title 158
Overexpression of serum amyloid A-activating factor 1 inhibits cell proliferation by the induction of cyclin-dependent protein kinase inhibitor p21WAF-1/Cip-1/Sdi-1 expression
###end article-title 158
###begin article-title 159
Specific transcriptional pausing activates polyadenylation in a coupled in vitro system
###end article-title 159
###begin article-title 160
Activation of the adenovirus major late promoter by transcription factors MAZ and Sp1
###end article-title 160
###begin article-title 161
Activation of Sp1 and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression
###end article-title 161
###begin article-title 162
The transcription factors SP1 and MAZ regulate expression of the parathyroid hormone/parathyroid hormone-related peptide receptor gene
###end article-title 162
###begin article-title 163
The Sp-family of transcription factors
###end article-title 163
###begin article-title 164
###xml 37 40 <span type="species:ncbi:10116">rat</span>
Parathyroid hormone (PTH) suppresses rat PTH/PTH-related protein receptor gene promoter
###end article-title 164
###begin article-title 165
Multiple Indexing Sequence Alignment for Group Feature Identification. The Third Annual RECOMB Satellite Workshop on Regulatory Genomics
###end article-title 165
###begin article-title 166
MISA-NTHU
###end article-title 166
###begin article-title 167
Progressive sequence alignment as a prerequisite to correct phylogenetic trees
###end article-title 167

